ArticleBioengineering (Basel, Switzerland)2025
Evaluation of Patient Benefits from the Superficial Circumflex Iliac Artery Perforator Flap in Elderly Patients.
Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pediatric free fillet of leg flap for external hemipelvectomy coverage: A case report and systematic review.JPRAS open · 2026Review
- [The clinical outcomes of using superficial circumflex iliac artery perforator flap and radial forearm free flap for reconstructing oral and maxillofacial soft tissue defects].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
backgroundThe superficial circumflex iliac artery perforator (SCIP) flap is widely recognized for its reliability and minimal donor site morbidity in reconstructive surgery. However, its safety and efficacy in elderly patients-a growing demographic with increased comorbidities-remain less understood. This study aims to evaluate the clinical outcomes of the SCIP flap in elderly patients compared to younger patients, focusing on flap survival, complications, and recovery.
methodsIn this retrospective cohort study, conducted at Guangdong Provincial People's Hospital, from 28 August 2019 to 7 June 2024, we included 37 patients who underwent SCIP flap procedures for reconstruction. Patients were divided into two groups: younger (15-59 years) and elderly (≥60 years). Key variables analyzed included demographics, comorbidities, flap characteristics, recipient sites, arterial sources, and surgical outcomes. Univariate analysis and ROC curve analysis were used to explore the impact of age on flap survival and complications.
resultsThe cohort consisted of 28 younger and 9 elderly patients. Vascular disease was significantly more prevalent in the elderly group (88.9% vs. 21.4%,
conclusionsThe SCIP flap is a safe and effective reconstructive option for elderly patients, despite a higher incidence of vascular disease. Flap survival and postoperative recovery were favorable, indicating that the procedure is viable for older patients. These findings support the continued use of SCIP flaps in aging populations, emphasizing the need for individualized surgical approaches to optimize patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.